[Signal analysis of EEG-changes induced by nomifensin - a new antidepressant (author's transl)].
Ten healthy volunteers received a single oral dose of 100 mg nomifensive, a new antidepressant (tetragtdriusiqyubikube deruvatuve; Hoe 36-984). The drug-induced effects on the EEG were compared with those of placebo. The statistically proved results show that nomifensine causes a distinct shift in vigilance with two different partial processes. After an initially occurring stabilization of the dominant alpha-frequency there appears a polyrhythmic disintegration of the alpha-rhythm with increase of slower and faster frequencies. At the same time a shifting takes place within the beta-range with increasing of 23.5-32.0 Hz-components. Accordingly it is evident that nomifensine results in a typical pharmaco-electroencephalographic profile.
D000513:Alpha Rhythm; D000928:Antidepressive Agents / Q000494:pharmacology*; D001143:Arousal / Q000187:drug effects; D001611:Beta Rhythm; D001921:Brain / Q000187:drug effects*; D004569:Electroencephalography; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology*
D000928:Antidepressive Agents; D007546:Isoquinolines
Signalanalytische Untersuchungen zur Wirkung des Antidepressivums Nomifensin auf das EEG gesunder Probanden